Business Context and Reporting Period
This Form 8-K is a current report filed by EzFill Holdings, Inc. (trading symbol: EZFL) on August 4, 2023, covering events occurring on July 31, 2023, and August 3, 2023. The registrant is an emerging growth company incorporated in Delaware. The filing primarily addresses amendments to a material definitive agreement regarding debt financing and the unregistered sale of equity securities for consulting services.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. Specific financial figures disclosed relate to capital structure adjustments:
- Debt Instrument: A promissory note with an aggregate principal amount of $1,500,000 issued to AJB Capital Investments, LLC.
- Equity Issuance (Consulting): Agreement to issue 75,000 shares of common stock to a consultant in exchange for services.
- Equity Issuance (Prior Financing): Reference to a prior issuance of 2,000,000 shares as a commitment fee.
Liquidity and debt maturity details are not explicitly quantified beyond the note principal and the extension of a shareholder approval deadline.
Material Changes
The filing reports two material changes compared to prior periods:
- Extension of Shareholder Approval Deadline: On August 3, 2023, the Company executed an amendment to its Securities Purchase Agreement with AJB Capital Investments, LLC. This amendment extends the deadline to obtain required shareholder approval to September 15, 2023.
- Unregistered Equity Sale: On July 31, 2023, the Company entered into an agreement to issue 75,000 shares of common stock to a consultant. These shares are to be issued in three tranches of 25,000 shares each.
Outlook, Risks, and Management Commentary
Management Commentary: The filing indicates ongoing efforts to secure shareholder approval for the $1.5 million promissory note and associated equity issuance. The extension of the deadline suggests the Company is actively working to finalize the transaction terms.
Risks and Contingencies:
- Approval Risk: The validity or finalization of the financing arrangement with AJB Capital Investments, LLC is contingent upon obtaining shareholder approval by the new deadline of September 15, 2023.
- Regulatory Compliance: The issuance of 75,000 shares to the consultant was conducted under Section 4(a)(2) of the Securities Act, relying on an exemption from registration requirements.
Unusual Items: The filing notes the appointment of Yehuda Levy as Interim Chief Executive Officer, who signed the report.
Investor Verification Checklist
- Verify the status of the shareholder approval required for the $1.5 million promissory note by the September 15, 2023 deadline.
- Confirm the terms of the consulting agreement and the vesting schedule for the 75,000 shares issued to the consultant.
- Review the full text of the "August Amendment" (Exhibit 10.1) for any additional covenants or conditions attached to the financing.
- Monitor future filings for the impact of the interim CEO appointment on corporate strategy.